Vancouver, British Columbia, Canada
From the University of British Columbia.
Received for publication December 2, 2013; accepted December 4, 2013.
Disclosure: The author is a consultant and researcher for Allergan, Merz, MerzGmbH, and Kythera, and a stockholder in Valeant Pharmaceuticals.
Jean Diana Carruthers, M.D., Department of Ophthalmology, University of British Columbia, 943 West Broadway, Suite 820, Vancouver, British Columbia, Canada V5Z 4E1, email@example.com